Cargando…

Sufficient blood, safe blood: can we have both?

The decision in September 2011 in the UK to accept blood donations from non-practicing men who have sex with men (MSM) has received significant public attention. Will this rule change substantially boost the number of blood donations or will it make our blood less safe? Clearly, most European countr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bönig, Halvard, Schmidt, Michael, Hourfar, Kai, Schüttrumpf, Jörg, Seifried, Erhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326707/ https://www.ncbi.nlm.nih.gov/pubmed/22439656 http://dx.doi.org/10.1186/1741-7015-10-29

Ejemplares similares

Blood Screening for Influenza
por: Hourfar, Michael Kai, et al.
Publicado: (2007)

CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust
por: Wiercinska, Eliza, et al.
Publicado: (2021)

Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss
por: Hahn-Klimroth, Max, et al.
Publicado: (2021)

Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors
por: Kim-Wanner, Soo-Zin, et al.
Publicado: (2020)

Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
por: Ehrend, Elisabeth, et al.
Publicado: (2021)

Safe Drugs Versus Innovative Drugs (Can We Have Both?)
por: Raposo, Vera Lúcia
Publicado: (2020)

Variant rs1801157 in the 3’UTR of SDF-1ß Does Not Explain Variability of Healthy-Donor G-CSF Responsiveness
por: Schulz, Miriam, et al.
Publicado: (2015)

Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site
por: Wiercinska, Eliza, et al.
Publicado: (2021)

Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure
por: Hümmer, Christiane, et al.
Publicado: (2016)

Novel multiple swab method enables high efficiency in SARS‐CoV‐2 screenings without loss of sensitivity for screening of a complete population
por: Schmidt, Michael, et al.
Publicado: (2020)

Blood management in intensive care medicine: CRIT and ABC – what can we learn?
por: Spahn, Donat R, et al.
Publicado: (2004)

Hypothermia, immune suppression and SDD: can we have our cake and eat it?
por: Polderman, Kees H
Publicado: (2011)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

Hematopoietic transcription factors and differential cofactor binding regulate PRKACB isoform expression
por: Kuvardina, Olga N., et al.
Publicado: (2017)

Have we been operating safely in 2015?
por: Wollmann, D, et al.
Publicado: (2016)

Ensuring a safe and adequate blood supply during the COVID-19 pandemic: the Moroccan National Blood Center experience
por: Bouhou, Sabah, et al.
Publicado: (2020)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

Implications of Confidential Unit Exclusion in Providing Sufficient Safe Blood for the National Health System
por: Cheraghali, Abdol Majid
Publicado: (2011)

The Patients We Have to See
por: Irwin, Kelly E.
Publicado: (2017)

Protein arginine methyltransferase 6 controls erythroid gene expression and differentiation of human CD34(+) progenitor cells
por: Herkt, Stefanie C., et al.
Publicado: (2018)

FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation
por: Steiner, Marlene, et al.
Publicado: (2019)

Paracetamol use in pregnancy: Not as safe as we may think?
por: Nilsen, Katinka, et al.
Publicado: (2023)

Biosimilar granulocyte–colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?
por: Bonig, Halvard, et al.
Publicado: (2015)

Performance and Interpretability in Fuzzy Logic Systems – Can We Have Both?
por: Pekaslan, Direnc, et al.
Publicado: (2020)

Disseminating trial results: We can have both faster and better
por: Simon, Gregory E., et al.
Publicado: (2020)

Plain packaging of cigarettes: do we have sufficient evidence?
por: Smith, Collin N, et al.
Publicado: (2015)

Cardiology and COVID-19: do we have sufficient information?
por: Garg, Nikita, et al.
Publicado: (2020)

Monkeypox virus in pregnancy, do we have sufficient evidence?
por: El-Qushayri, Amr Ehab
Publicado: (2023)

COVID 19: Have we nailed it?
por: Gogia, Atul
Publicado: (2021)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1
por: Schneider, Lucas, et al.
Publicado: (2021)

Commentary: The times have changed: Are we listening?
por: Grover, A K
Publicado: (2019)

We have to get it right: Ensuring success
por: Mokdad, Ali H., et al.
Publicado: (2020)

COVID-19 deaths can be reduced – simply and safely!
por: Ylikoski, Jukka, et al.
Publicado: (2020)

Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC
por: Kim-Wanner, Soo-Zin, et al.
Publicado: (2017)

Commentary: Because we can
por: Hanna, Waël C.
Publicado: (2020)

Traumatic brain injury and resuscitation with blood products: what should we do?
por: Oh, Bryan C, et al.
Publicado: (2011)

Commentary: We are in the same minimally invasive boat, and we have to row in the same direction
por: Bertolaccini, Luca, et al.
Publicado: (2020)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

Can a simple blood test quantify brain injury?
por: Mayer, Stephan A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r20bfib2eogsum6uboaed97aj1